Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.77 USD | -0.36% | -3.38% | -4.04% |
Chart calendar Supernus Pharmaceuticals, Inc.
Upcoming events on Supernus Pharmaceuticals, Inc.
Past events on Supernus Pharmaceuticals, Inc.
2024-05-23 04:30 pm | R&D Day |
2024-05-08 04:30 pm | Q1 2024 Earnings Call |
2024-05-08 04:05 pm | Q1 2024 Earnings Release |
2024-03-13 03:35 pm | Barclays Global Healthcare Conference |
2024-03-11 | Jefferies Biotech on the Bay Summit |
2024-03-06 09:10 am | TD Cowen Health Care Conference |
2024-02-27 04:30 pm | Q4 2023 Earnings Call |
2024-02-27 04:05 pm | Q4 2023 Earnings Release |
2023-11-15 09:00 am | Jefferies London Healthcare Conference |
2023-11-08 04:30 pm | Q3 2023 Earnings Call |
2023-11-08 04:05 pm | Q3 2023 Earnings Release |
2023-10-18 08:30 am | R&D Day |
2023-09-06 11:00 am | Wells Fargo Healthcare Conference |
2023-08-08 04:30 pm | Q2 2023 Earnings Call |
2023-08-08 04:05 pm | Q2 2023 Earnings Release |
2023-06-16 10:00 am | Annual General Meeting |
2023-06-07 01:00 pm | Jefferies Global Healthcare Conference |
2023-05-11 01:40 pm | Bank of America Healthcare Conference - Fireside Chat |
2023-05-09 04:30 pm | Q1 2023 Earnings Call |
2023-05-09 04:05 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 393 399 -1.62% | 520 523 -0.5% | 580 579 0.19% | 667 680 -1.92% | 608 598 1.55% | 600 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 192 167 14.87% | 119 103 15.17% | 129 130 -0.82% | 97,3 91,2 6.67% | 117 |
EBIT Million USD | Released Forecast Spread | 149 150 -0.75% | 174 172 0.79% | 86,0 107 -19.26% | 46,1 40,0 15.17% | 125 104 20.75% | 108 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 147 148 -0.2% | 169 171 -1.16% | 73,2 93,6 -21.84% | 60,7 54,6 11.33% | 2,77 0,67 310.83% | 11,6 |
Net income Million USD | Released Forecast Spread | 113 112 1.28% | 127 128 -0.72% | 53,4 66,3 -19.37% | 60,7 95,2 -36.26% | 1,32 -1,22 207.52% | 14,2 |
EPS USD | Released Forecast Spread | 2,10 2,07 1.55% | 2,36 2,38 -0.74% | 0,98 1,21 -19.18% | 1,04 1,11 -5.88% | 0,02 -0,06 133.33% | 0,25 |
Announcement Date | 25/02/20 | 25/02/21 | 13/04/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 153 150 1.35% | 170 164 3.55% | 177 172 2.83% | 167 180 -7.23% | 154 139 10.6% | 136 144 -5.63% | 154 143 7.32% | 164 155 5.99% | 144 146 -1.5% | 149 | 153 | 154 | 149 | 155 |
EBITDA Million USD | Released Forecast Spread | 22,6 15,7 44.33% | 32,0 20,9 53.39% | 19,1 20,1 -5.03% | 55,0 48,9 12.54% | 25,1 6,57 282.68% | 2,52 7,81 -67.71% | 29,4 4,49 555.07% | 40,3 20,4 97.41% | 17,0 31,5 -46.14% | 32,6 | 34,3 | 32,2 | 43,3 | 42,1 |
EBIT Million USD | Released Forecast Spread | 1,97 21,6 -90.87% | 11,3 19,9 -42.85% | -1,52 -0,87 -75.66% | 34,3 28,3 21.5% | 30,5 23,4 30.34% | 10,0 14,5 -30.98% | 8,14 6,73 20.85% | 47,1 26,3 78.76% | 22,3 22,9 -2.69% | 25,4 | 29,4 | 31,1 | 27,1 | 30,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 14,7 25,3 -41.81% | 11,3 21,2 -46.46% | -0,44 27,8 -101.59% | 35,1 34,3 2.39% | 9,02 -12,9 169.74% | -17,1 -11,7 -46.48% | 9,89 -15,0 165.86% | 0,99 -1,11 189.59% | 0,24 -3,48 106.98% | 2,38 | 8,38 | 0,64 | ||
Net income Million USD | Released Forecast Spread | 25,6 13,1 95.92% | 7,87 18,1 -56.45% | 1,75 21,9 -92% | 25,5 28,2 -9.6% | 16,9 -16,0 206.13% | -0,83 -14,4 94.25% | -16,0 -15,7 -1.62% | 1,18 -1,37 186.08% | 0,12 -4,30 102.88% | 2,94 | 10,3 | 0,79 | ||
EPS USD | Released Forecast Spread | 0,43 0,45 -4.44% | 0,14 0,29 -51.72% | 0,03 0,36 -91.59% | 0,43 0,52 -16.77% | 0,29 -0,26 211.54% | -0,02 -0,23 91.3% | -0,29 -0,29 0% | 0,02 -0,02 200% | 0,00 -0,08 - | 0,05 | 0,18 | 0,01 | ||
Announcement Date | 09/05/22 | 04/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 27/02/24 | 08/05/24 | - | - | - | - | - |
Past sector events for Supernus Pharmaceuticals, Inc.
2024-05-23 01:00 am | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
2024-05-15 01:00 am | MERCK KGAA: Q1 2024 Earnings Release |
2024-05-12 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-05-13 | OSCOTEC INC.: Q1 2024 Earnings Release |
2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SUPN Stock
- Calendar Supernus Pharmaceuticals, Inc.